Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence

J. D. Pradeep; G. P. R. Clunie; K. Gaffney; N. J. Innes; A. Brooksby; P. Bradley; A. Gulati

doi:10.1093/rheumatology/ken425

Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence

J. D. Pradeep
, G. P. R. Clunie
, K. Gaffney
, N. J. Innes
, A. Brooksby
, P. Bradley
, A. Gulati

Norwich Medical School

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	195
Number of pages	1
Journal	Rheumatology
Volume	48
Issue number	2
DOIs	https://doi.org/10.1093/rheumatology/ken425
Publication status	Published - Feb 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

England
Humans
Immunosuppressive Agents/administration & dosage
Mycobacterium tuberculosis/isolation & purification
Practice Guidelines as Topic
Rheumatology
Tuberculosis/diagnosis
Tumor Necrosis Factor-alpha/antagonists & inhibitors

Access to Document

10.1093/rheumatology/ken425

Cite this

Pradeep, J. D., Clunie, G. P. R., Gaffney, K., Innes, N. J., Brooksby, A., Bradley, P., & Gulati, A. (2009). Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence. Rheumatology, 48(2), 195. https://doi.org/10.1093/rheumatology/ken425

@article{09d5ee3685414ef985a3a9697d1c93bb,

title = "Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence",

keywords = "England, Humans, Immunosuppressive Agents/administration \& dosage, Mycobacterium tuberculosis/isolation \& purification, Practice Guidelines as Topic, Rheumatology, Tuberculosis/diagnosis, Tumor Necrosis Factor-alpha/antagonists \& inhibitors",

author = "Pradeep, \{J. D.\} and Clunie, \{G. P. R.\} and K. Gaffney and Innes, \{N. J.\} and A. Brooksby and P. Bradley and A. Gulati",

year = "2009",

month = feb,

doi = "10.1093/rheumatology/ken425",

language = "English",

volume = "48",

pages = "195",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "2",

}

Pradeep, JD, Clunie, GPR, Gaffney, K, Innes, NJ, Brooksby, A, Bradley, P & Gulati, A 2009, 'Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence', Rheumatology, vol. 48, no. 2, pp. 195. https://doi.org/10.1093/rheumatology/ken425

Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence. / Pradeep, J. D.; Clunie, G. P. R.; Gaffney, K. et al.
In: Rheumatology, Vol. 48, No. 2, 02.2009, p. 195.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence

AU - Pradeep, J. D.

AU - Clunie, G. P. R.

AU - Gaffney, K.

AU - Innes, N. J.

AU - Brooksby, A.

AU - Bradley, P.

AU - Gulati, A.

PY - 2009/2

Y1 - 2009/2

KW - England

KW - Humans

KW - Immunosuppressive Agents/administration & dosage

KW - Mycobacterium tuberculosis/isolation & purification

KW - Practice Guidelines as Topic

KW - Rheumatology

KW - Tuberculosis/diagnosis

KW - Tumor Necrosis Factor-alpha/antagonists & inhibitors

U2 - 10.1093/rheumatology/ken425

DO - 10.1093/rheumatology/ken425

M3 - Letter

C2 - 19033354

SN - 1462-0324

VL - 48

SP - 195

JO - Rheumatology

JF - Rheumatology

IS - 2

ER -